Developments in the scientific and clinical understanding of autoinflammatory disorders

Arthritis Research and Therapy

Volumn 11, Issue 1, 2009, Pages

  Lachmann, Helen J ^a   Hawkins, Philip N ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALCIUM PYROPHOSPHATE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD2 BINDING PROTEIN 1; CELL PROTEIN; COLCHICINE; CORTICOSTEROID; CRYOPYRIN; CYTOKINE RECEPTOR; DEATH RECEPTOR; ETANERCEPT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; MEVALONATE KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN MEFV; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SERUM AMYLOID A; TNFRSF1A; UNCLASSIFIED DRUG; URATE;

AMYLOIDOSIS; AUTOINFLAMMATORY DISEASE; BIRTH DEFECT; BLAU SYNDROME; CAUSE OF DEATH; CRYOPYRIN ASSOCIATED PERIODIC SYNDROME; DIARRHEA; DISEASE COURSE; DNA DETERMINATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG PROTEIN BINDING; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GOUT; HEREDITARY PERIODIC FEVER; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOLOGY; INFERTILITY; INNATE IMMUNITY; KIDNEY FAILURE; LIFE EXPECTANCY; LOW DRUG DOSE; MISSENSE MUTATION; NONHUMAN; PAPA SYNDROME; PATHOPHYSIOLOGY; PROGNOSIS; PSEUDOGOUT; REVIEW; SCHNITZLER SYNDROME; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; DIFFERENTIAL DIAGNOSIS; FEVER; GENETICS; IMMUNOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEVER; HUMANS;

EID: 60549102686     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2579     Document Type: Review

References (70)

1. Heller H Sohar E Sherf L Familial Mediterranean fever AMA Arch Intern Med 1958, 102:50-71. 13558745
2. Consortium TFF A candidate gene for familial Mediterranean fever Nat Genet 1997, 17:25-31. 10.1038/ng0997-25 9288094
3. Consortium TIF Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever Cell 1997, 90:797-807. 10.1016/S0092-8674(00)80539-5 9288758
4. Centola M Wood G Frucht DM Galon J Aringer M Farrell C Kingma DW Horwitz ME Mansfield E Holland SM O'Shea JJ Rosenberg HF Malech HL Kastner DL The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators Blood 2000, 95:3223-3231. 10807793
5. Infevers homepage http://fmf.igh.cnrs.fr/ISSAID/infevers
6. Lachmann HJ Sengül B Yavuzsen TU Booth DR Booth SE Bybee A Gallimore JR Soytürk M Akar S Tunca M Hawkins PN Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations Rheumatology (Oxford) 2006, 45:746-750. 10.1093/rheumatology/kei279 16403826
7. Booth DR Gillmore JD Lachmann HJ Booth SE Bybee A Soytürk M Akar S Pepys MB Tunca M Hawkins PN The genetic basis of autosomal dominant familial Mediterranean fever QJM 2000, 93:217-221. 10.1093/qjmed/ 93.4.217 10787449
8. Cañete JD Arostegui JI Queiró R Gratacós J Hernández MV Larrosa M Alperí M Moll C Rius J Sanmartí R Yagüe J An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism Arthritis Rheum 2007, 56:2784-2788. 10.1002/ art.22755 17665427
9. Kalyoncu M Acar BC Cakar N Bakkaloglu A Ozturk S Dereli E Tunca M Kasapcopur O Yalcinkaya F Ozen S Are carriers for MEFV mutations "healthy"? Clin Exp Rheumatol 2006, 24:S120-122. 17067442
10. Hall MW Gavrilin MA Knatz NL Duncan MD Fernandez SA Wewers MD Monocyte mRNA phenotype and adverse outcomes from pediatric multiple organ dysfunction syndrome Pediatr Res 2007, 62:597-603. 17805202
11. Tidow N Chen X Müller C Kawano S Gombart AF Fischel-Ghodsian N Koeffler HP Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin Blood 2000, 95:1451-1455. 10666224
12. Martinon F Hofmann K Tschopp J The pyrin domain: A possible member of the death domain-fold family implicated in apoptosis and inflammation Curr Biol 2001, 10:R118-R120. 10.1016/S0960-9822(01)00056-2 11250163
13. Park HH Lo YC Lin SC Wang L Yang JK Wu H The death domain superfamily in intracellular signaling of apoptosis and inflammation Annu Rev Immunol 2007, 25:561-586. 10.1146/annurev.immunol.25.022106.141656 17201679
14. Chae JJ Wood G Masters SL Richard K Park G Smith BJ Kastner DL The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production Proc Natl Acad Sci USA 2006, 103:9982-9987. 1479864 16785446 10.1073/pnas.0602081103
15. Chae JJ Wood G Richard K Jaffe H Colburn NT Masters SL Gumucio DL Shoham NG Kastner DL The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment Blood 2008, 112:1794-1803. 10.1182/blood-2008-01-134932 18577712
16. Mikula M Buller A Sun W Strom CM Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations Genet Med 2008, 10:349-352. 18496034
17. Ross JJ Goats, germs, and fever: Are the pyrin mutations responsible for familial Mediterranean fever protective against Brucellosis? Med Hypotheses 2007, 68:499-501. 10.1016/j.mehy.2006.07.027 17005326
18. Schaner P Richards N Wadhwa A Aksentijevich I Kastner D Tucker P Gumucio D Episodic evolution of pyrin in primates: Human mutations recapitulate ancestral amino acid states Nat Genet 2001, 27:318-321. 10.1038/85893 11242116
19. Goldfinger SE Colchicine for familial Mediterranean fever N Engl J Med 1972, 287:1302. 4636899
20. Rigante D La Torraca I Avallone L Pugliese AL Gaspari S Stabile A The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever Eur Rev Med Pharmacol Sci 2006, 10:173-178. 16910346
21. Chia EW Grainger R Harper JL Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: A rationale for use of low-dose colchicine Br J Pharmacol 2008, 153:1288-1295. 10.1038/ bjp.2008.20 18264123
22. Ben-Chetrit E Levy M Reproductive system in familial Mediterranean fever: An overview Ann Rheum Dis 2003, 62:916-919. 1754343 12972465 10.1136/ard.62.10.916
23. Mor A Pillinger MH Kishimoto M Abeles AM Livneh A Familial Mediterranean fever successfully treated with etanercept J Clin Rheumatol 2007, 13:38-40. 10.1097/01.rhu.0000255772.25658.7c 17278949
24. Roldan R Ruiz AM Miranda MD Collantes E Anakinra: New therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine Joint Bone Spine 2008, 75:504-505. 10.1016/ j.jbspin.2008.04.001 18541452
25. McDermott MF Aksentijevich I Galon J McDermott EM Ogunkolade BW Centola M Mansfield E Gadina M Karenko L Pettersson T McCarthy J Frucht DM Aringer M Torosyan Y Teppo AM Wilson M Karaarslan HM Wan Y Todd I Wood G Schlimgen R Kumarajeewa TR Cooper SM Vella JP Amos CI Mulley J Quane KA Molloy MG Ranki A Powell RJ et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes Cell 1999, 97:133-144. 10.1016/S0092-8674(00)80721-7 10199409
26. D'Osualdo A Ferlito F Prigione I Obici L Meini A Zulian F Pontillo A Corona F Barcellona R Di Duca M Santamaria G Traverso F Picco P Baldi M Plebani A Ravazzolo R Ceccherini I Martini A Gattorno M Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: Pathogenetic and clinical implications Arthritis Rheum 2006, 54:998-1008. 10.1002/art.21657 16508982
27. Rebelo SL Bainbridge SE Amel-Kashipaz MR Radford PM Powell RJ Todd I Tighe PJ Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function Arthritis Rheum 2006, 54:2674-2687. 10.1002/art.21964 16871532
28. Todd I Radford PM Daffa N Bainbridge SE Powell RJ Tighe PJ Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes Arthritis Rheum 2007, 56:2765-2773. 10.1002/art.22740 17665435
29. Nedjai B Hitman GA Yousaf N Chernajovsky Y Stjernberg-Salmela S Pettersson T Ranki A Hawkins PN Arkwright PD McDermott MF Turner MD Abnormal tumor necrosis factor receptor I cell surface expression and NF-κB activation in tumor necrosis factor receptor-associated periodic syndrome Arthritis Rheum 2008, 58:273-283. 10.1002/art.23123 18163488
30. Williamson LM Hull D Mehta R Reeves WG Robinson BH Toghill PJ Familial Hibernian fever QJM 1982, 51:469-480. 7156325
31. Tchernitchko D Chiminqgi M Galactéros F Préhu C Segbena Y Coulibaly H Rebaya N Loric S Unexpected high frequency of P46L TNFRSF1A allele in sub-Saharan West African populations Eur J Hum Genet 2005, 13:513-515. 10.1038/sj.ejhg.5201344 15586174
32. Ravet N Rouaghe S Dodé C Bienvenu J Stirnemann J Lévy P Delpech M Grateau G Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene Ann Rheum Dis 2006, 65:1158-1162. 10.1136/ard.2005.048611 16569687
33. Hoffmann LA Lohse P Konig FB Feneberg W Hohlfeld R Kumpfel T TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome Neurology 2008, 70:1155-1156. 10.1212/ 01.wnl.0000296279.98236.8a 18287568
34. Nowlan ML Drewe E Bulsara H Esposito N Robins RA Tighe PJ Powell RJ Todd I Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A Rheumatology (Oxford) 2006, 45:31-37. 10.1093/rheumatology/ kei090 16287931
35. Gattorno M Pelagatti MA Meini A Obici L Barcellona R Federici S Buoncompagni A Plebani A Merlini G Martini A Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome Arthritis Rheum 2008, 58:1516-1520. 10.1002/art.23475 18438813
36. Meer van der JW Vossen JM Radl J van Nieuwkoop JA Meyer CJ Lobatto S van Furth R Hyperimmunoglobulinaemia D and periodic fever: A new syndrome Lancet 1984, 1:1087-1090. 6144826
37. Cuisset L Drenth JP Simon A Vincent MF Velde Visser van der S Meer van der JW Grateau G Delpech M International Hyper-IgD Study Group Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome Eur J Hum Genet 2001, 9:260-266. 10.1038/ sj.ejhg.5200614 11313769
38. Houten SM Frenkel J Waterham HR Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation Cell Mol Life Sci 2003, 60:1118-1134. 12861380
39. Schneiders MS Houten SM Turkenburg M Wanders RJ Waterham HR Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency Arthritis Rheum 2006, 54:2306-2313. 10.1002/ art.21960 16802371
40. Simon A Drewe E Meer van der JW Powell RJ Kelley RI Stalenhoef AF Drenth JP Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome Clin Pharmacol Ther 2004, 75:476-483. 10.1016/j.clpt.2004.01.012 15116060
41. Hoffmann GF Charpentier C Mayatepek E Mancini J Leichsenring M Gibson KM Divry P Hrebicek M Lehnert W Sartor K Trefz FK Rating D Bremer HJ Nyhan WL Clinical and biochemical phenotype in 11 patients with mevalonic aciduria Pediatrics 1993, 91:915-921. 8386351
42. Hyper-IgD and periodic fever syndrome (HIDS) homepage http://www.hids.net
43. Houten SM van Woerden CS Wijburg FA Wanders RJ Waterham HR Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands Eur J Hum Genet 2003, 11:196-200. 10.1038/sj.ejhg.5200933 12634869
44. Drenth JP Haagsma CJ Meer van der JW Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group Medicine (Baltimore) 1994, 73:133-144. 8190036
45. Houten SM Frenkel J Rijkers GT Wanders RJ Kuis W Waterham HR Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome Hum Mol Genet 2002, 11:3115-3124. 10.1093/hmg/11.25.3115 12444096
46. Ammouri W Cuisset L Rouaghe S Rolland MO Delpech M Grateau G Ravet N Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome Rheumatology (Oxford) 2007, 46:1597-1600. 10.1093/rheumatology/kem200 17804452
47. Takada K Aksentijevich I Mahadevan V Dean JA Kelley RI Kastner DL Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome Arthritis Rheum 2003, 48:2645-2651. 10.1002/art.11218 13130485
48. Lachmann HJ Goodman HJ Andrews PA Gallagher H Marsh J Breuer S Rowczenio DM Bybee A Hawkins PN AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: A report of two cases Arthritis Rheum 2006, 54:2010-2014. 10.1002/art.21901 16732551
49. Hoffman HM Wright FA Broide DH Wanderer AA Kolodner RD Identification of a locus on chromosome 1q44 for familial cold urticaria Am J Hum Genet 2000, 66:1693-1698. 1378006 10741953 10.1086/302874
50. Tschopp J Martinon F Burns K NALPs: A novel protein family involved in inflammation Nat Rev Mol Cell Biol 2003, 4:95-104. 10.1038/nrm1019 12563287
51. Martinon F Agostini L Meylan E Tschopp J Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome Curr Biol 2004, 14:1929-1934. 10.1016/j.cub.2004.10.027 15530394
52. Hawkins PN Lachmann HJ McDermott MF Interleukin-1-receptor antagonist in the Muckle-Wells syndrome N Engl J Med 2003, 348:2583-2584. 10.1056/ NEJM200306193482523 12815153
53. Leslie KS Lachmann HJ Bruning E McGrath JA Bybee A Gallimore JR Roberts PF Woo P Grattan CE Hawkins PN Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations Arch Dermatol 2006, 142:1591-1597. 10.1001/archderm.142.12.1591 17178985
54. Muckle TJ Wells MV Urticaria, deafness and amyloidosis: A new heredofamilial syndrome QJM 1962, 31:235-248. 14476827
55. Prieur AM Griscelli C Lampert F Truckenbrodt H Guggenheim MA Lovell DJ Pelkonnen P Chevrant-Breton J Ansell BM A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients Scand J Rheumatol Suppl 1987, 66:57-68. 10.3109/03009748709102523 3482735
56. Goldbach-Mansky R Dailey NJ Canna SW Gelabert A Jones J Rubin BI Kim HJ Brewer C Zalewski C Wiggs E Hill S Turner ML Karp BI Aksentijevich I Pucino F Penzak SR Haverkamp MH Stein L Adams BS Moore TL Fuhlbrigge RC Shaham B Jarvis JN O'Neil K Vehe RK Beitz LO Gardner G Hannan WP Warren RW Horn W et al Neonatal-onset multisystem inflammatory disease responsive to interleukin-1b inhibition N Engl J Med 2006, 355:581-592. 10.1056/NEJMoa055137 16899778
57. Hoffman HM Throne ML Amar NJ Sebai M Kivitz AJ Kavanaugh A Weinstein SP Belomestnov P Yancopoulos GD Stahl N Mellis SJ Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies Arthritis Rheum 2008, 58:2443-2452. 10.1002/art.23687 18668535
58. Goldbach-Mansky R Shroff SD Wilson M Snyder C Plehn S Barham B Pham TH Pucino F Wesley RA Papadopoulos JH Weinstein SP Mellis SJ Kastner DL A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome Arthritis Rheum 2008, 58:2432-2442. 10.1002/art.23620 18668591
59. Wise CA Gillum JD Seidman CE Lindor NM Veile R Bashiardes S Lovett M Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder Hum Mol Genet 2002, 11:961-969. 10.1093/hmg/11.8.961 11971877
60. Shoham NG Centola M Mansfield E Hull KM Wood G Wise CA Kastner DL Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway Proc Natl Acad Sci USA 2003, 100:13501-13506. 263843 14595024 10.1073/pnas.2135380100
61. Yu JW Fernandes-Alnemri T Datta P Wu J Juliana C Solorzano L McCormick M Zhang Z Alnemri ES Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants Mol Cell 2007, 28:214-227. 10.1016/j.molcel.2007.08.029 17964261
62. Blau EB Familial granulomatous arthritis, iritis, and rash J Pediatr 1985, 107:689-693. 10.1016/S0022-3476(85)80394-2 4056967
63. Miceli-Richard C Lesage S Rybojad M Prieur AM Manouvrier-Hanu S Häfner R Chamaillard M Zouali H Thomas G Hugot JP CARD15 mutations in Blau syndrome Nat Genet 2001, 29:19-20. 10.1038/ng720 11528384
64. de Koning HD Bodar EJ Meer van der JW Simon A Schnitzler syndrome: beyond the case reports: Review and follow-up of 94 patients with an emphasis on prognosis and treatment Semin Arthritis Rheum 2007, 37:137-148. 10.1016/j.semarthrit.2007.04.001 17586002
65. Martinon F Petrilli V Mayor A Tardivel A Tschopp J Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 2006, 440:237-241. 10.1038/nature04516 16407889
66. So A De Smedt T Revaz S Tschopp J A pilot study of IL-1 inhibition by anakinra in acute gout Arthritis Res Ther 2007, 9:R28. 1906806 17352828 10.1186/ar2143
67. Lachmann HJ Goodman HJ Gilbertson JA Gallimore JR Sabin CA Gillmore JD Hawkins PN Natural history and outcome in systemic AA amyloidosis N Engl J Med 2007, 356:2361-2371. 10.1056/NEJMoa070265 17554117
68. Ledue TB Weiner DL Sipe JD Poulin SE Collins MF Rifai N Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum Ann Clin Biochem 1998, 35:745-753. 9838988
69. Aganna E Hawkins PN Ozen S Pettersson T Bybee A McKee SA Lachmann HJ Karenko L Ranki A Bakkaloglu A Besbas N Topaloglu R Hoffman HM Hitman GA Woo P McDermott MF Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis Genes Immun 2004, 5:289-293. 10.1038/sj.gene.6364070 15071491
70. Aksentijevich I Galon J Soares M Mansfield E Hull K Oh HH Goldbach-Mansky R Dean J Athreya B Reginato AJ Henrickson M Pons-Estel B O'Shea JJ Kastner DL The tumornecrosis-factor receptor-associated periodic syndrome: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers Am J Hum Genet 2001, 69:301-314. 1235304 11443543 10.1086/321976